Showing results 1 - 10 of 16
September 24, 2024, Paper: "This paper analyzes a minimalist version of the behavioral “Susceptible-Infectious-Recovered" model of infectious disease where the incentives for…
February 2024, Paper: "Biotech innovations lead to the development of life-saving drugs and vaccines. However, bringing a new drug to market is an expensive, risky, and time-…
December 4, 2023, Paper: "Notwithstanding concerns about staffing levels and burnout in health care, federal wage and employment data does not support the suggestion that a Covid-…
Fall 2023, Paper: "COVID-19 and the war in Ukraine have exposed the vulnerabilities
of deep economic integration. Shortening supply chains, rebuilding domestic pro-
duction…
July 14, 2022, Paper: "To what extent does pharmaceutical revenue growth depend on new medicines versus increasing prices for existing medicines? Moreover, does using list prices…
2021, Book: "The world is increasingly confronted with new challenges related to climate change, globalization, disease, and technology. Governments are faced with having to…
December 22, 2020, Audio: "Youngme Moon, Felix Oberholzer-Gee, and Mihir Desai invite their new co-hosts, Harvard Business School professors Rebecca Henderson…
July 2020, Paper, "In this paper, we develop a heterogeneous agent general equilibrium framework to analyze optimal joint policies of a lockdown and transfer payments in times of…
July 29, 2020, Video, "As coronavirus cases continue to surge across the country, David Rubenstein interviewed Ashish K. Jha, MD, MPH, Director, Harvard Global Health Institute on…
July 21, 2020, Video, "Professor Sunil Gupta of Harvard Business School in conversation with Bejul Somaia, Partner Lightspeed Venture Partners lifts the chalk to write on a fresh…